Professor, Medicine, UCSF School of Medicine
Infectious Disease
Dr. Phyllis C. Tien, MD
|
|
Give Review
Phyllis C. Tien, MD works in the field of Infectious Disease. She attended University of California San Diego School of Medicine. University of California San Diego School of Medicine has a rank of 17 in research and a 19 in primary care Doctor Phyllis C. Tien, MD is a published doctor and has 101 publications published. The lastest was: 'Mechanisms For The Negative Effects Of Internalized Hiv-Related Stigma On Art Adherence In Women: The Mediating Roles Of Social Isolation And Depression.'
Publications
- Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
- Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.
- Mechanisms For The Negative Effects Of Internalized Hiv-Related Stigma On Art Adherence In Women: The Mediating Roles Of Social Isolation And Depression.
- Novel Approaches to Targeting Visceral and Hepatic Adiposities in HIV-Associated Lipodystrophy.
- The association of adiposity with kidney function decline among HIV-infected adults: findings from the Fat Redistribution and Metabolic Changes in HIV Infection (FRAM)...
- Human immunodeficiency virus (HIV) modulates the associations between insulin resistance and cognition in the current combination antiretroviral therapy (cART) era: a ...
- Echolucency of the carotid artery intima-media complex and intima-media thickness have different cardiovascular risk factor relationships: the Women's Interagency HIV ...
- Teriparatide treatment of osteoporosis in an HIV-infected man: a case report and literature review.
- Association of Urine α1-Microglobulin with Kidney Function Decline and Mortality in HIV-Infected Women.
- Association of Markers of Hemostasis With Death in HIV-Infected Women.
- T-Cell Activation, Both Pre- and Post-HAART Levels, Correlates With Carotid Artery Stiffness Over 6.5 Years Among HIV-Infected Women in the WIHS.
- Investigating the effects of metabolic dysregulation on hair follicles: a comparison of HIV-infected women with and without central lipohypertrophy.
- Serum Albumin and Kidney Function Decline in HIV-Infected Women.
- Metabolic Syndrome, Diabetes, and Cardiovascular Risk in HIV.
- A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans.
- Antiretroviral therapy modifies the genetic effect of known type 2 diabetes-associated risk variants in the Women's Interagency HIV Study.
- Relationship of Vitamin D, HIV, HIV Treatment, and Lipid Levels in the Women's Interagency HIV Study of HIV-Infected and Uninfected Women in the United States.
- Macrophage Inflammatory Markers Are Associated With Subclinical Carotid Artery Disease in Women With Human Immunodeficiency Virus or Hepatitis C Virus Infection.
- Pilot Study of Pioglitazone Before HCV Retreatment in HIV/HCV Genotype 1-Infected Subjects With Insulin Resistance and Previous Nonresponse to Peginterferon and Ribavi...
- Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women's Interagency HIV Study.
- HIV/HCV coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infection.
- Does HIV infection promote early kidney injury in women?
- Association of HIV infection, HCV infection and Metabolic Factors with Liver Stiffness measured by Transient Elastography.
- Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach.
- Vitamin D and Insulin Resistance in Non-Diabetic Women's Interagency HIV Study Participants.
- Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women.
- The association of self-perception of body fat changes and quality of life in the Women's Interagency HIV Study.
- Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women's Interagency HIV Study.
- Gonadotropin and Sex Steroid Levels in HIV-Infected Premenopausal Women and Their Association With Subclinical Atherosclerosis in HIV-Infected and -Uninfected Women in...
- Vitamin D insufficiency may impair CD4 recovery among Women's Interagency HIV Study participants with advanced disease on HAART.
- Serum Albumin and Short-Term Risk for Mortality and Cardiovascular Disease among HIV-Infected Veterans.
- Antiretroviral-Treated HIV-Infected Women Have Similar Long-Term Kidney Function Trajectories as HIV-Uninfected Women.
- The association between diet and physical activity on insulin resistance in the Women's Interagency HIV Study.
- Association Of Hepatitis C With Markers Of Hemostasis In HIV-Infected and Uninfected Women in the Women's Interagency HIV Study (WIHS).
- Racial/Ethnic Differences in Spontaneous HCV Clearance in HIV Infected and Uninfected Women.
- Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women.
- Association of Regional Body Composition with Bone Mineral Density in HIV-infected and Uninfected Women: Women's Interagency HIV Study.
- Association of HIV infection with Incident Diabetes Mellitus: Impact of using Hemoglobin A1C as a Criterion for Diabetes.
- Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.
- Marginal Structural Models for Case-Cohort Study Designs to Estimate the Association of Antiretroviral Therapy Initiation With Incident AIDS or Death.
- Assessing mortality in women with hepatitis C virus and human immunodeficiency virus using indirect markers of fibrosis.
- Conceptual framework for understanding the bidirectional links between food insecurity and HIV/AIDS.
- Liver diffusivity in healthy volunteers and patients with chronic liver disease: Comparison of breathhold and free-breathing techniques.
- Insulin Resistance and Cognition Among HIV-Infected and HIV-Uninfected Adult Women: The Women's Interagency HIV Study.
- Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study.
- Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection.
- Circulating microRNAs in hepatitis B virus-infected patients.
- Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy.
- Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States.
- Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals.
- Regional anthropometry changes in antiretroviral-naïve persons initiating a Zidovudine-containing regimen in Mbarara, Uganda.
- Association of Low Level Viremia with Inflammation and Mortality in HIV-Infected Adults.
- HIV, HAART, and lipoprotein particle concentrations in the Women''s Interagency HIV Study.
- Fracture incidence in HIV-infected women: results from the Women''s Interagency HIV Study.
- Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.
- Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.
- The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.
- Adipose tissue and metabolic factors associated with steatosis in HIV/HCV coinfection: histology versus magnetic resonance spectroscopy.
- Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thickness.
- Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection.
- Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy.
- Glycated haemoglobin in diabetic women with and without HIV infection: data from the Women''s Interagency HIV Study.
- The effects of opiate use and hepatitis C virus infection on risk of diabetes mellitus in the Women's Interagency HIV Study.
- Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus.
- Time scale and adjusted survival curves for marginal structural cox models.
- Short-term bone loss in HIV-infected premenopausal women.
- Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or death.
- Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era.
- Hormonal contraception and metabolic outcomes in women with or at risk for HIV infection.
- Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study.
- Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study.
- Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women''s interagency HIV study.
- Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study.
- Respiratory motion-corrected proton magnetic resonance spectroscopy of the liver.
- Self-Perception of Body Fat Changes and HAART Adherence in the Women's Interagency HIV Study.
- Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV study.
- Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers.
- Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men.
- Hormonal contraception and HIV-positive women: metabolic concerns and management strategies.
- Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study.
- Regional adipose tissue and elevations in serum aminotransferases in HIV-infected individuals.
- Regional adipose tissue and lipid and lipoprotein levels in HIV-infected women.
- Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women.
- Resolution of hepatitis C virus-induced steatosis improves tolerability of antiretroviral drugs associated with hepatotoxicity in an HIV-infected individual.
- Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected women.
- Illicit drug use and HIV treatment outcomes in a US cohort.
- Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression.
- Correlates of prevalent hypertension in a large cohort of HIV-infected women: Women''s Interagency HIV Study.
- The association of bone mineral density with HIV infection and antiretroviral treatment in women.
- Ten-year predicted coronary heart disease risk in HIV-infected men and women.
- Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women.
- Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women''s Interagency HIV Study.
- Obesity and immune cell counts in women.
- Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women.
- Antiretroviral therapies associated with lipoatrophy in HIV-infected women.
- Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens.
- Association between hepatitis C virus coinfection and regional adipose tissue volume in HIV-infected men and women.
- Factors associated with seronegative chronic hepatitis C virus infection in HIV infection.
- Relation of stavudine discontinuation to anthropometric changes among HIV-infected women.
- Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for ...
Schools
University of California At San Diego
University Colo School Med
Stanford University School Med Hospital
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
University of California San Diego School of Medicine
Hospital
-
San Francisco VA Medical Center -
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Daniella J. Perlroth, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Moupali D. Das, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne F. Luetkemeyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George F. Brooks Jr., MD |
|
|
Dr. Julie L. Gerberding, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Uri A. Lopatin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter M. Dull, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Sears, MD |
|
|
Dr. Emily B. Wong, MD |
|
|
Dr. Matthew M. Ippolito, MD |